Josue Samayoa

1.9k total citations · 1 hit paper
17 papers, 671 citations indexed

About

Josue Samayoa is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Josue Samayoa has authored 17 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Josue Samayoa's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (4 papers) and Ferroptosis and cancer prognosis (4 papers). Josue Samayoa is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (4 papers) and Ferroptosis and cancer prognosis (4 papers). Josue Samayoa collaborates with scholars based in United States, Netherlands and Qatar. Josue Samayoa's co-authors include Francesco M. Marincola, Rongze Lu, Alessandra Cesano, Patrick Danaher, Amy Sullivan, Irena Pekker, Sarah Warren, Brett Wallden, Ralph H. Hruban and Hannah Carter and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and The Journal of Immunology.

In The Last Decade

Josue Samayoa

17 papers receiving 657 citations

Hit Papers

Pan-cancer adaptive immune resistance as defined by the T... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
    2018 294 citations Patrick Danaher, Sarah Warren et al. Journal for ImmunoTherapy of Cancer profile →

Peers

Josue Samayoa
Kimberly M. Komatsubara United States
Ryota Sekine Japan
Sterre T. Paijens Netherlands
Akihiro Hosoi Japan
Mélanie Desbois France
Youssef Youssef United States
Leah Schmidt United States
Aatish Thennavan United States
Karmele Valencia Spain
Kimberly M. Komatsubara United States
Josue Samayoa
Citations per year, relative to Josue Samayoa Josue Samayoa (= 1×) peers Kimberly M. Komatsubara

Countries citing papers authored by Josue Samayoa

Since Specialization
Citations

This map shows the geographic impact of Josue Samayoa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josue Samayoa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josue Samayoa more than expected).

Fields of papers citing papers by Josue Samayoa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josue Samayoa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josue Samayoa. The network helps show where Josue Samayoa may publish in the future.

Co-authorship network of co-authors of Josue Samayoa

This figure shows the co-authorship network connecting the top 25 collaborators of Josue Samayoa. A scholar is included among the top collaborators of Josue Samayoa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josue Samayoa. Josue Samayoa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ma, Liqian, Jacob Pfeil, Hui‐Wen Lo, et al.. (2025). Abstract A099: The IO-Atlas Project: A cross-cohort tumor immunophenotyping platform enhancing precision immuno-oncology. Cancer Immunology Research. 13(2_Supplement). A099–A099. 1 indexed citations
2.
Zhang, Baoyi, et al.. (2025). Multimodal integration strategies for clinical application in oncology. Frontiers in Pharmacology. 16. 1609079–1609079. 1 indexed citations
3.
Turan, Tolga, et al.. (2023). Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment. Cancer Drug Resistance. 6(3). 611–41. 17 indexed citations
4.
Turan, Tolga, Sarah Kongpachith, Kyle Halliwill, et al.. (2023). iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration. Cancer Immunology Research. 11(6). 732–746. 2 indexed citations
5.
Goenka, Radhika, Josue Samayoa, David Banach, et al.. (2021). CTLA4-Ig–Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function. The Journal of Immunology. 206(5). 1102–1113. 7 indexed citations
6.
Thakur, Archana, Melvin Fox, Enrico L. DiGiammarino, et al.. (2020). Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity. Molecular Cancer Therapeutics. 19(4). 1040–1051. 30 indexed citations
7.
Turan, Tolga, Sarah Kongpachith, Kyle Halliwill, et al.. (2020). A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival. British Journal of Cancer. 124(4). 760–769. 17 indexed citations
8.
Turan, Tolga, Sarah Kongpachith, Kyle Halliwill, et al.. (2020). Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival. British Journal of Cancer. 124(7). 1340–1340. 13 indexed citations
9.
Purcell, James W., Jonathan A. Hickson, Melvin Fox, et al.. (2018). LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates. Cancer Research. 78(14). 4059–4072. 136 indexed citations
10.
Danaher, Patrick, Sarah Warren, Rongze Lu, et al.. (2018). Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). Journal for ImmunoTherapy of Cancer. 6(1). 63–63. 294 indexed citations breakdown →
11.
Turan, Tolga, Maulik Patel, J. Matthew Barnes, et al.. (2018). Immune oncology, immune responsiveness and the theory of everything. Journal for ImmunoTherapy of Cancer. 6(1). 50–50. 46 indexed citations
12.
Pai, Sara I., Daniel Clayburgh, Mihir R. Patel, et al.. (2018). ICR gene signature to identify differential immune landscapes in anatomic subsites of head and neck squamous cell carcinomas and implications in personalized medicine.. Journal of Clinical Oncology. 36(15_suppl). 6052–6052. 2 indexed citations
13.
Lu, Rongze, Tolga Turan, Josue Samayoa, & Francesco M. Marincola. (2017). Cancer immune resistance: can theories converge?. Emerging Topics in Life Sciences. 1(5). 411–419. 9 indexed citations
14.
Belmar, Nicole A., Sarah Chan, Melvin Fox, et al.. (2017). Murinization and H Chain Isotype Matching of the Anti-GITR Antibody DTA-1 Reduces Immunogenicity-Mediated Anaphylaxis in C57BL/6 Mice. The Journal of Immunology. 198(11). 4502–4512. 2 indexed citations
15.
Hickson, Jonathan A., Melvin Fox, David Chao, et al.. (2016). ABBV-085 is a novel antibody–drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment. European Journal of Cancer. 69. S10–S10. 1 indexed citations
16.
Samayoa, Josue, Fitnat H. Yildiz, & Kevin Karplus. (2011). Identification of prokaryotic small proteins using a comparative genomic approach. Bioinformatics. 27(13). 1765–1771. 31 indexed citations
17.
Carter, Hannah, Josue Samayoa, Ralph H. Hruban, & Rachel Karchin. (2010). Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). Cancer Biology & Therapy. 10(6). 582–587. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly M. Komatsubara Breakdown of academic impact, for papers by Ryota Sekine Breakdown of academic impact, for papers by Sterre T. Paijens Breakdown of academic impact, for papers by Akihiro Hosoi Breakdown of academic impact, for papers by Mélanie Desbois Breakdown of academic impact, for papers by Youssef Youssef Breakdown of academic impact, for papers by Leah Schmidt Breakdown of academic impact, for papers by Aatish Thennavan Breakdown of academic impact, for papers by Karmele Valencia
Rankless by CCL
2026